Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Jowell Global | JWEL | Nov 22, 2024 | 3.38 | +5.30 |
JOYY ADR | YY | Nov 22, 2024 | 33.91 | -5.88 |
JP Morgan Chase | JPM | Nov 22, 2024 | 248.55 | +1.55 |
JP Morgan Chase & Co EE Pref | JPM-C | Nov 22, 2024 | 25.38 | -0.08 |
JP Morgan Chase & Co GG Pref | JPM-J | Nov 22, 2024 | 22.25 | +0.47 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Nov 22, 2024 | 25.17 | -0.08 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Nov 22, 2024 | 56.57 | +0.18 |
Jumia Technologies ADR | JMIA | Nov 22, 2024 | 3.80 | +4.40 |
Junee Limited - Ordinary Shares | JUNE | Nov 22, 2024 | 5.00 | +0.20 |
Junior Gold Miners ETF Market Vectors | GDXJ | Nov 22, 2024 | 48.34 | -0.19 |
Juniper Networks | JNPR | Nov 22, 2024 | 35.91 | +1.35 |
JVSPAC Acquisition | JVSA | Nov 22, 2024 | 10.38 | 0.00 |
JVSPAC Acquisition | JVSAU | Nov 22, 2024 | 10.90 | 0.00 |
JX Luxventure | JXJT | Nov 22, 2024 | 1.20 | +0.84 |
Kadant | KAI | Nov 22, 2024 | 419.01 | +2.59 |
Kairos Pharma | KAPA | Nov 22, 2024 | 1.60 | 0.00 |
Kairous Acquisition | KACL | Nov 22, 2024 | 12.50 | +0.32 |
Kaiser Aluminium | KALU | Nov 22, 2024 | 81.65 | +0.58 |
Kaival Brands Innovations Group | KAVL | Nov 22, 2024 | 0.79 | -2.03 |
Kaixin Holdings | KXIN | Nov 22, 2024 | 2.12 | -9.01 |
Kala Bio | KALA | Nov 22, 2024 | 6.79 | +3.74 |
Kaltura | KLTR | Nov 22, 2024 | 2.10 | -4.55 |
KalVista Pharmaceuticals | KALV | Nov 22, 2024 | 10.15 | +8.85 |
Kamada | KMDA | Nov 22, 2024 | 5.87 | +0.34 |
Kandi Technologies Group | KNDI | Nov 22, 2024 | 1.23 | +6.96 |
Kanzhun ADR | BZ | Nov 22, 2024 | 12.76 | -1.24 |
Karat Packaging | KRT | Nov 22, 2024 | 30.64 | +3.51 |
Karooooo | KARO | Nov 22, 2024 | 41.35 | +2.07 |
Kartoon Studios | TOON | Nov 22, 2024 | 0.78 | +0.94 |
Karyopharm Therapeutics | KPTI | Nov 22, 2024 | 0.84 | +8.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.